Pharmacological treatment of canine atopic dermatitis includes corticosteroids, cyclosporine and JAK inhibitors, which are effective in the short term but burdened with systemic side effects. The modern holistic approach aims to reduce the pharmacological burden by integrating natural immunomodulators such as Ribes Nigrum and PEA to preserve the body’s homeostasis.
1. Drug Therapy: Managing Urgency in Atopic Dermatitis
When the itching becomes disabling and the skin inflammation severe, the veterinarian resorts to pharmacological protocols to break the vicious circle of scratching. It is crucial to understand that these drugs act on the symptoms (immune suppression) and not on the root causes of the damaged skin barrier.
Cortisone: Prednisone and Methylprednisolone
Cortisone is often the first choice because of its speed and cost-effectiveness. However, it does not “cure” dermatitis, but “turns off” the immune response.
- Advantages: Immediate effect, low cost, different formulations.
- Long-term risks: Liver disease, gastrointestinal ulcers, iatrogenic diabetes and cystitis.
- Contraindications: Renal insufficiency, pancreatitis and hyperadrenocorticism (Cushing’s).
2. Immunosuppressants and Selective Inhibitors: Cyclosporine and Oclacitinib
In addition to corticosteroids, veterinary pharmacology offers more selective molecules, but which require constant monitoring.
Cyclosporine
An immunosuppressant that inhibits the production of cytokines such as IL-2 and IL-4, blocking the response of T and B lymphocytes.
- Disadvantages: It acts slowly and can cause gingival hyperplasia, vomiting and mucus stools. Symptoms often reappear upon discontinuation.
Oclacitinib (Janus Kinase Inhibitor – JAK)
It provides quick relief from itching by blocking inflammation’s cell signaling pathways.
- Caution: It can increase susceptibility to infections (pyoderma, otitis, cystitis) and aggravate pre-existing neoplastic conditions. The occurrence of skin nodules or lymphadenopathies should be monitored.
3. Comparative Table of Pharmacological Therapies
| Medication | Mechanism of action | Main side effects | Monitoring Required |
| Corticosteroids | Total immune suppression | Polydipsia, polyphagia, ulcers, diabetes | Liver and renal profile |
| Cyclosporine | IL-2 and IL-4 inhibition | Gastrointestinal disorders, gingival hyperplasia | Digestive function |
| Oclacitinib | JAK inhibitor (Janus kinase) | Secondary infections, new skin nodules | Cancer screening, blood count |
| Antihistamines | H1 receptor blockade | Drowsiness, poor efficacy in chronic | Preventive effectiveness only |
4. Towards a Complementary Therapy: Reducing the Pharmacological Burden
The goal of functional medicine is not necessarily to eliminate every drug, but to create a healthy biological soil so that as little as possible can be used.
Alternatives and Targeted Integrations I Recommend
- Ribes Nigrum: Considered a “natural cortisone”, it stimulates the adrenal glands to produce endogenous cortisol without suppressing the immune system.
- Medicinal Mushrooms (Reishi): They modulate the Th1/Th2 balance, reducing the allergic hyperactivity typical of the atopic dog.
- Ginger: It acts as a powerful natural anti-inflammatory, protecting the gastric mucosa often irritated by systemic drugs.
FAQ Atopic Dermatitis Dogs and Drugs
Answer: No, cortisone temporarily removes itching and reduces inflammation, but it does not cure the causes of atopic dermatitis. As a powerful immunosuppressant, its prolonged use can promote secondary infections and damage internal organs such as the liver and kidneys.
Answer: Oclacitinib may cause vomiting, diarrhea, lethargy, and polydipsia. Because it modulates the immune response, it can increase the risk of infections (cystitis, otitis) and facilitate the development of skin neoplasms or nodules, requiring constant veterinary monitoring.
Answer: Among the most effective natural remedies, Ribes Nigrum stands out for its “cortisone-like” action. Other options include Reishi mushroom to modulate the immune system, ginger for inflammation, and PEA for biological control of mast cell itch.
Answer: Antihistamines have limited efficacy when given when the itching is already intense. They work best as preventatives in cases of mild dermatitis, as they must block the receptors before histamine is massively released by mast cells.
Answer: Cyclosporine is approved for long-term use, but it is an expensive and slow-acting drug. It can cause gingival hyperplasia and gastric upset. It is essential not to use it in the presence of previous neoplasms or gastrointestinal ulcers. 
Article published 2021 – Revised 2026
Disclaimer: The Contents Are For Informational Purposes Only And Under No Circumstances Can They Constitute A Prescription Of A Treatment Or Substitute For A Specialist Visit Or Direct Relationship With Your Veterinarian/Doctor. All information reported here is derived from bibliographic sources, personal experiences and clinical studies in the public domain. All information on special diets and dietary supplements for pets is for informational purposes. This information serves as a general guideline, cannot be applied to all pets or considered as an alternative to professional advice. These pages include “Homeopathic preparations of non-scientifically validated efficacy and without approved therapeutic indications. The products are not intended as a substitute for a varied and balanced diet and must be used as part of a healthy lifestyle. Disclaimer and terms
Bibliography
Ferguson, Ewan A., Littlewood, Janet D., Carlotti, Didier-Noël, Grover, Rob & Nuttall, Tim (2006): Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study. In: Veterinary Dermatology 17(4), 236-243
Han, Na-Ra, et al. “Cordycepin ameliorates skin inflammation in a DNFB-challenged murine model of atopic dermatitis.” Immunopharmacology and immunotoxicology (2018): 1-7.
Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97 (3): 828-37.
Iwamoto, Kazumasa, et al. “Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized towards TLR 2 activation.” Allergy (2018).
Ricklin, M. E., Roosje, P., & Summerfield, A. (2010). Characterization of canine dendritic cells in healthy, atopic, and non-allergic inflamed skin. Journal of clinical immunology, 30(6), 845-854.
Isolauri E, Salminen S. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. J Clin Gastroenterol 2008; 42(Suppl.2):S91-96
Maeda S, Fujiwara S, Omori K, et al. Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis. Vet Immunol Immunopathol 2002; 88 (1-2): 79-87
© Copyright – This article is the property of the site Elicats.it- the author prohibits its reproduction and copying without explicit authorization –
